Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eduardo Forleo-Neto

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Revista Da Sociedade Brasileira De Medicina Tropical|June 14, 2003
[Influenza]Eduardo Forleo-Neto, Elisa Halker, Verônica Jorge Santos, et al.
Human Vaccines & Immunotherapeutics|June 21, 2016
Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority studyStephan Bart, Kevin Cannon, Darrell Herrington, et al.
Aviation, Space, and Environmental Medicine|September 18, 2002
Impact of influenza vaccination on civilian aircrew illness and absenteeismMarias A G Mixéu, Glaucia N R Vespa, Eduardo Forleo-Neto, et al.
The Pediatric Infectious Disease Journal|September 24, 2015
Comparative Assessment of a Single Dose and a 2-dose Vaccination Series of a Quadrivalent Meningococcal CRM-conjugate Vaccine (MenACWY-CRM) in Children 2-10 Years of AgeWilliam Johnston, Brandon Essink, Judith Kirstein, et al.
Journal of Travel Medicine|December 9, 2014
Immunogenicity and safety of concomitant administration of a combined hepatitis A/B vaccine and a quadrivalent meningococcal conjugate vaccine in healthy adultsMartin Alberer, Gerd Burchard, Tomas Jelinek, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 21, 2015
Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trialRobyn Hartvickson, Marilou Cruz, John Ervin, et al.
Journal of Travel Medicine|October 14, 2014
Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adultsMartin Alberer, Gerd Burchard, Tomas Jelinek, et al.
Travel Medicine and Infectious Disease|May 31, 2014
Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: a randomized, open-label, multi-center studyMartin Alberer, Gerd Burchard, Tomas Jelinek, et al.
Vaccine|July 22, 2014
Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjectsSharon E Frey, Mari Rose Aplasca-De Los Reyes, Humberto Reynales, et al.
Journal of Clinical Pharmacology|June 20, 2020
Pharmacokinetics and Pharmacodynamics of Garetosmab (Anti-Activin A): Results From a First-in-Human Phase 1 StudyFrédéric Vanhoutte, Su Liang, Marcella Ruddy, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Revista Da Sociedade Brasileira De Medicina Tropical|June 14, 2003
[Influenza]Eduardo Forleo-Neto, Elisa Halker, Verônica Jorge Santos, et al.
Human Vaccines & Immunotherapeutics|June 21, 2016
Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority studyStephan Bart, Kevin Cannon, Darrell Herrington, et al.
Aviation, Space, and Environmental Medicine|September 18, 2002
Impact of influenza vaccination on civilian aircrew illness and absenteeismMarias A G Mixéu, Glaucia N R Vespa, Eduardo Forleo-Neto, et al.
The Pediatric Infectious Disease Journal|September 24, 2015
Comparative Assessment of a Single Dose and a 2-dose Vaccination Series of a Quadrivalent Meningococcal CRM-conjugate Vaccine (MenACWY-CRM) in Children 2-10 Years of AgeWilliam Johnston, Brandon Essink, Judith Kirstein, et al.
Journal of Travel Medicine|December 9, 2014
Immunogenicity and safety of concomitant administration of a combined hepatitis A/B vaccine and a quadrivalent meningococcal conjugate vaccine in healthy adultsMartin Alberer, Gerd Burchard, Tomas Jelinek, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 21, 2015
Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trialRobyn Hartvickson, Marilou Cruz, John Ervin, et al.
Journal of Travel Medicine|October 14, 2014
Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adultsMartin Alberer, Gerd Burchard, Tomas Jelinek, et al.
Travel Medicine and Infectious Disease|May 31, 2014
Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: a randomized, open-label, multi-center studyMartin Alberer, Gerd Burchard, Tomas Jelinek, et al.
Vaccine|July 22, 2014
Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjectsSharon E Frey, Mari Rose Aplasca-De Los Reyes, Humberto Reynales, et al.
Journal of Clinical Pharmacology|June 20, 2020
Pharmacokinetics and Pharmacodynamics of Garetosmab (Anti-Activin A): Results From a First-in-Human Phase 1 StudyFrédéric Vanhoutte, Su Liang, Marcella Ruddy, et al.
Pageof 3